Sickle Cell and Transfusion: Bridging the Gap in Patient Care

This ISBT corporate partner webinar is intended for Scientists, blood bankers, transfusion practitioners, practitioners in immuno hematology laboratory.

It is recommended that you read the following publications prior to the webinar:

• Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S, Hendrickson JE, Stowell SR. Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6. PMID: 32029505; PMCID: PMC7049330.
• Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143. PMID: 31985807; PMCID: PMC6988392.
• Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood. 2018 Jun 21;131(25):2773-2781. doi: 10.1182/blood-2018-02-785964. Epub 2018 May 3. PMID: 29724898; PMCID: PMC6014354.
• Chou ST, Hendrickson JE. How I Treat Challenging Transfusion Cases in Sickle Cell Disease. Blood. 2024 May 10:blood.2023023648. doi: 10.1182/blood.2023023648. Epub ahead of print. PMID: 38728382

This event is listed in Central European Time.

Please be aware that if you attend the webinar, your data will be shared with Grifols Diagnostic. If you do not want your data to be shared, please send ISBT an email.

Presented by

France Pirenne
Head of Transfusion and Pathologies of the Red Blood Cell, Mondor Biomedical Research Institute
Creteil, France

Greg Denomme
Director of Medical Affairs at Grifols Diagnostic Solutions, Grifols Diagnostic Solutions

Learning objectives

After participating in this educational activity, participants should be able to:

• Understand transfusion difficulties in sickle cell disease and implement appropriate analyses.
• Prevent, diagnose and treat post-transfusion hemolysis in patients with sickle cell disease

Registration

For additional event details and registration, visit the ISBT website